Skybiotech Healthcare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	62.86	70.52	-	-	-	-
Other Revenue	-0.3	3.84	20.02	0.54	0.23	0.2
Revenue	62.56	74.36	20.02	0.54	0.23	0.2
Revenue Growth (YoY)	-13.15%	271.34%	3597.53%	138.36%	16.26%	-59.55%
Cost of Revenue	35.25	37.73	-	-	-	-
Gross Profit	27.31	36.62	20.02	0.54	0.23	0.2
Selling, General & Admin	17.45	19.63	0.19	0.12	0.16	0.16
Other Operating Expenses	26.94	35.7	1.08	0.48	0.43	0.49
Operating Expenses	49.43	60.75	1.27	0.62	0.61	0.68
Operating Income	-22.11	-24.12	18.75	-0.07	-0.38	-0.48
Interest Expense	-	-0.12	-	-	-	-
Currency Exchange Gain (Loss)	-0.01	-0.01	-	-	-	-
Other Non Operating Income (Expenses)	-0	-0	-0	-	-	-
EBT Excluding Unusual Items	-19.97	-24.26	18.75	-0.07	-0.38	-0.48
Pretax Income	-19.97	-24.26	18.75	-0.07	-0.38	-0.48
Income Tax Expense	-1.02	-0.57	3.4	-0	0	-0
Net Income	-18.95	-23.69	15.35	-0.07	-0.38	-0.48
Net Income to Common	-18.95	-23.69	15.35	-0.07	-0.38	-0.48
Shares Outstanding (Basic)	-	2	2	1	1	1
Shares Outstanding (Diluted)	-	2	2	1	1	1
Shares Change (YoY)	-	0.00%	84.14%	-	-	-
EPS (Basic)	-	-12.37	8.02	-0.07	-0.36	-0.46
EPS (Diluted)	-	-12.37	8.02	-0.07	-0.36	-0.46
Free Cash Flow	-	-13.68	-13.37	-3.73	6.1	12.8
Free Cash Flow Per Share	-	-7.14	-6.98	-3.59	5.86	12.31
Gross Margin	43.66%	49.25%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-35.35%	-32.44%	93.64%	-13.62%	-166.50%	-246.70%
Profit Margin	-30.30%	-31.86%	76.68%	-13.37%	-166.58%	-246.26%
Free Cash Flow Margin	-	-18.40%	-66.76%	-688.68%	2683.86%	6550.84%
EBITDA	-12.64	-18.71	18.76	-0.06	-0.36	-0.46
EBITDA Margin	-20.21%	-25.16%	93.68%	-10.83%	-156.29%	-234.15%
D&A For EBITDA	9.47	5.42	0.01	0.02	0.02	0.02
EBIT	-22.11	-24.12	18.75	-0.07	-0.38	-0.48
EBIT Margin	-35.35%	-32.44%	93.64%	-13.62%	-166.50%	-246.69%
Effective Tax Rate	-	-	18.12%	-	-	-
Revenue as Reported	62.55	74.35	20.02	0.54	0.23	0.21
Advertising Expenses	-	-	0.04	0.01	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.